Topics

Vyndaqel | Vyndaqel [Pfizer Labs Division of Pfizer Inc.] | BioPortfolio

12:43 EST 27th January 2019 | BioPortfolio
Note: While we endeavour to keep our records up-to-date one should not rely on these details being accurate without first consulting a professional. Click here to read our full medical disclaimer.

Vyndaqel 20 mg

tafamidis meglumina

Pfizer

Vyndaqel 20 mg

tafamidis meglumina Pfizer

Manufacturer

Pfizer Labs Division of Pfizer Inc.

Active Ingredients

Source

Drugs and Medications [0 Results]

None

Clinical Trials [0 Results]

None

PubMed Articles [0 Results]

None

Quick Search

Relevant Topics

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...


Drugs and Medication Quicklinks


Searches Linking to this Drug Record